It is one of humanity’s ultimate scientific and technological quests, alongside putting a man on the moon and unlocking the structure of DNA. Now the biotech industry’s progress in developing age-reversing treatments that could revolutionise the quality of life of millions of older people is entering a crucial new phase.
Just three years after its creation, the leader in this field, Altos Labs, appears to be ready to start planning full-scale human clinical trials for the first time. The moment of truth may finally be close. Can scientists really turn back the clock?
